Histogen Profit Margin

The latest profit margin for HSTO is -65173.68% as of September 2023. That compares with -299.2% in the prior-year period — down 21682.3% year over year. That is below the Healthcare sector average of 13.71%. Investors often review this figure alongside Histogen's historical trend and sector peers before judging valuation or financial health.

Over the past year, HSTO's profit margin moved from -299.2% to -65173.68% — a 21682.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Histogen's valuation or profitability profile.

Against Healthcare companies, HSTO currently prints -65173.68% for profit margin, while the sector average sits near 13.71%. That is roughly 475444.1% below the sector mean. Large gaps often invite a closer look at Histogen's growth, margins, and balance sheet.

Profit Margin shows how effectively Histogen converts resources into returns. At -65173.68%, HSTO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -299.2% in the prior-year period — down 21682.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting HSTO's profit margin (-65173.68%), review year-over-year change from -299.2%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.